Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 68

1.

Percutaneous coronary intervention in pediatric and adolescent patients.

Schneider AE, Johnson JN, Taggart NW, Cabalka AK, Hagler DJ, Reeder GS, Cetta F.

Congenit Heart Dis. 2014 May-Jun;9(3):228-34. doi: 10.1111/chd.12130.

PMID:
23947956
3.

Unprotected left main coronary artery stenting with zotarolimus (Endeavor) drug-eluting stents: a single center retrospective experience.

Simard T, Hibbert B, Chong AY, Ruchin P, Le May M, Labinaz M, Froeschl M, So D, Glover C, Marquis JF, O'Brien E.

Catheter Cardiovasc Interv. 2012 Aug 1;80(2):E15-22. doi: 10.1002/ccd.23244.

PMID:
21805580
4.

The independent value of a direct stenting strategy on early and late clinical outcomes in patients undergoing elective percutaneous coronary intervention.

Sardi GL, Laynez-Carnicero A, Torguson R, Xue Z, Suddath WO, Kent KM, Satler LF, Pichard AD, Lindsay J, Waksman R.

Catheter Cardiovasc Interv. 2013 May;81(6):949-56. doi: 10.1002/ccd.24581.

PMID:
22888029
5.

Impact of concomitant treatment with proton pump inhibitors and clopidogrel on clinical outcome in patients after coronary stent implantation.

Tentzeris I, Jarai R, Farhan S, Brozovic I, Smetana P, Geppert A, Wojta J, Siller-Matula J, Huber K.

Thromb Haemost. 2010 Dec;104(6):1211-8. doi: 10.1160/TH10-04-0218.

PMID:
20941464
6.
7.

Emergent use of balloon-expandable coronary artery stenting for failed percutaneous transluminal coronary angioplasty.

Herrmann HC, Buchbinder M, Clemen MW, Fischman D, Goldberg S, Leon MB, Schatz RA, Tierstein P, Walker CM, Hirshfeld JW Jr.

Circulation. 1992 Sep;86(3):812-9.

PMID:
1516193
8.

Origin of the right coronary artery from the opposite sinus of Valsalva in adults: characterization by intravascular ultrasonography at baseline and after stent angioplasty.

Angelini P, Uribe C, Monge J, Tobis JM, Elayda MA, Willerson JT.

Catheter Cardiovasc Interv. 2015 Aug;86(2):199-208. doi: 10.1002/ccd.26069.

9.

Percutaneous coronary intervention using drug-eluting stents in pediatric heart transplant recipients.

Sachdeva R, Seib PM, Frazier EA, Sachdeva R.

Pediatr Transplant. 2009 Dec;13(8):1014-9. doi: 10.1111/j.1399-3046.2008.01118.x.

PMID:
19207219
10.

Four-year follow-up of TYPHOON (trial to assess the use of the CYPHer sirolimus-eluting coronary stent in acute myocardial infarction treated with BallOON angioplasty).

Spaulding C, Teiger E, Commeau P, Varenne O, Bramucci E, Slama M, Beatt K, Tirouvanziam A, Polonski L, Stella PR, Clugston R, Fajadet J, de Boisgelin X, Bode C, CarriƩ D, Erglis A, Merkely B, Hosten S, Cebrian A, Wang P, Stoll HP, Henry P.

JACC Cardiovasc Interv. 2011 Jan;4(1):14-23. doi: 10.1016/j.jcin.2010.10.007.

11.

In-hospital and mid-term outcomes of stent implantation in patients with protected and unprotected left main coronary artery disease; King Chulalongkorn Memorial Hospital experiences.

Cholteesupachai J, Udayachalerm W, Srimahachota S, Buddhari W, Chaipromprasit J, Songmuang SB, Suithichaiyakul T.

J Med Assoc Thai. 2009 Jun;92(6):755-60.

PMID:
19530580
12.
13.

Impact of angiographic and intravascular ultrasound features on clinical outcome after sirolimus-eluting stent implantation for de-novo lesions in nondiabetic and type 2 diabetic patients.

Du R, Zhang RY, Zhu ZB, Zhang Q, Hu J, Yang ZK, Yan ZJ, Lv AK, Ding FH, Zhang JS, Shen WF.

Coron Artery Dis. 2010 May;21(3):175-81. doi: 10.1097/MCA.0b013e32833811fe.

PMID:
20305549
14.

Impact of sex on 3-year outcome after percutaneous coronary intervention using bare-metal and drug-eluting stents in previously untreated coronary artery disease: insights from the RESEARCH (Rapamycin-Eluting Stent Evaluated at Rotterdam Cardiology Hospital) and T-SEARCH (Taxus-Stent Evaluated at Rotterdam Cardiology Hospital) Registries.

Onuma Y, Kukreja N, Daemen J, Garcia-Garcia HM, Gonzalo N, Cheng JM, van Twisk PH, van Domburg R, Serruys PW; Interventional Cardiologists of Thoraxcenter..

JACC Cardiovasc Interv. 2009 Jul;2(7):603-10. doi: 10.1016/j.jcin.2009.03.016.

15.

Effect of peripheral arterial disease in patients undergoing percutaneous coronary intervention with intracoronary stents.

Singh M, Lennon RJ, Darbar D, Gersh BJ, Holmes DR Jr, Rihal CS.

Mayo Clin Proc. 2004 Sep;79(9):1113-8.

PMID:
15357032
16.

Long-term outcome of provisional side-branch T-stenting for the treatment of unprotected distal left main coronary artery disease.

De Luca L, Altamura L, Corvo P, De Persio G, Ghini AS, Petrolini A, Aurigemma C, Tomai F.

Catheter Cardiovasc Interv. 2011 May 1;77(6):765-72. doi: 10.1002/ccd.22899.

PMID:
21413124
17.

Clinical and angiographic outcome after cutting balloon angioplasty.

Auer J, Maurer E, Berent R, Mayr H, Punzengruber C, Weber T, Lassnig E, Eber B.

J Interv Cardiol. 2003 Feb;16(1):15-21.

PMID:
12664813
18.

Comparison of drug-eluting stent with bare metal stent for distal de novo unprotected left main coronary artery stenosis. A propensity score-matched cohort study.

Hsueh SK, Wu CJ, Fang HY, Hsieh YK, Fang CY, Chen CJ, Chen SM, Yang CH, Yip HK, Chen MC, Fu M, Cheng CI.

Circ J. 2011;75(2):290-8.

19.

Clinical outcome of percutaneous treatment of in-stent restenosis with drug-eluting stents: results from the first phase of the prospective multicentre German DES.DE registry.

Abdel-Wahab M, Nienaber CA, Mostafa AE, Sabin G, Tebbe U, Hochadel M, Senges J, Akin I, Kuck KH, Hamm C, Richardt G; German Drug-Eluting Stent (DES.DE) registry..

EuroIntervention. 2011 Jun;7(2):201-8. doi: 10.4244/EIJV7I2A34.

20.

Medium to long-term clinical outcomes with everolimus-eluting stents in real-life percutaneous coronary intervention.

Liang M, Liew TV, Puri A, Hyde L, Devlin G.

Ann Acad Med Singapore. 2012 Jun;41(6):252-7.

Items per page

Supplemental Content

Support Center